ResMed Inc (RMD)

Return on assets (ROA)

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Net income (ttm)	US$ in thousands	1,020,950	958,378	890,386	906,500	897,556	862,953	809,465	786,302	779,437	779,476	521,983	499,746	474,505	457,240	698,858	679,898	621,674	512,640	454,919	419,004
Total assets	US$ in thousands	6,872,390	6,814,560	6,905,090	6,740,790	6,751,710	6,713,880	6,676,100	5,177,560	5,095,850	4,905,260	4,734,740	4,729,170	4,728,120	4,585,720	4,572,860	4,620,840	4,587,380	4,510,540	4,353,940	4,154,560
ROA		14.86%	14.06%	12.89%	13.45%	13.29%	12.85%	12.12%	15.19%	15.30%	15.89%	11.02%	10.57%	10.04%	9.97%	15.28%	14.71%	13.55%	11.37%	10.45%	10.09%

June 30, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $1,020,950K ÷ $6,872,390K
= 14.86%

ResMed Inc's return on assets (ROA) has shown a generally positive trend over the past several quarters, reflecting the company's ability to generate profits relative to its total assets. The ROA has ranged from 9.97% to 15.89% over the past several quarters.

The company's ROA was relatively stable in the range of 10% to 12% in early 2021 and late 2022, before showing an uptrend in mid-2022 to mid-2023, reaching a peak of 15.89%. The ROA then dipped slightly in late 2023 but remained above 12%. In the most recent quarter, the ROA was 14.86%, indicating a strong performance in generating profits from its assets.

Overall, ResMed Inc's ROA indicates efficient asset utilization and effective management in generating earnings from its total asset base. It is important for investors to track ROA over time to assess the company's operational efficiency and profitability.